04/25/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/09/2024
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:07 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:56 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
5:03 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:33 PM | Olian Judy D. (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Klein Katherine J (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:52 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:50 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:03 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:31 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
5:03 AM | United Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:36 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:57 PM | ROTHBLATT MARTINE A (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
02/14/2024
8:05 AM | Avoro Capital Advisors LLC (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
8:50 AM | RENAISSANCE TECHNOLOGIES LLC (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
9:18 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/08/2024
5:00 AM | Celularity Inc (Subject)
Celularity Inc (Subject)
United Therapeutics (Filed by)
| Form SC 13G/A | |
02/02/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:29 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
01/18/2024
4:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:12 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:06 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:51 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC 13D | |
12/21/2023
3:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:00 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:53 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:30 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:40 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
1:06 PM | Miromatrix Medical Inc. (Issuer)
United Therapeutics (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2023
4:29 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
9:03 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T/A | |
12/12/2023
3:37 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
9:52 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T/A | |
12/07/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
3:30 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
5:00 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:01 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
5:06 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T | |
11/08/2023
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
4:24 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:50 PM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
11/01/2023
5:03 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
6:06 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
10/30/2023
6:09 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
10/20/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2023
4:54 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
3:23 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:23 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
4:12 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
4:53 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:19 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
08/04/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:11 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
5:02 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
5:08 AM | United Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/24/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:30 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
5:30 AM | Klein Katherine J (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:30 AM | KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
